These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2261137

  • 1. Therapy for HIV-1-related nephritis with zidovudine.
    Harrer T, Hunzelmann N, Stoll R, Baur A, Kalden JR.
    AIDS; 1990 Aug; 4(8):815-7. PubMed ID: 2261137
    [No Abstract] [Full Text] [Related]

  • 2. Zidovudine therapy of asymptomatic HIV1-infected patients and combined zidovudine-acyclovir therapy of HIV1-infected patients with oral hairy leukoplakia.
    Brockmeyer NH, Kreuzfelder E, Mertins L, Daecke C, Goos M.
    J Invest Dermatol; 1989 Apr; 92(4):647. PubMed ID: 2703729
    [No Abstract] [Full Text] [Related]

  • 3. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E.
    Med Clin (Barc); 1995 Apr 01; 104(12):463-7. PubMed ID: 7739285
    [No Abstract] [Full Text] [Related]

  • 4. New developments in antiretroviral drug therapy for HIV-1 infections.
    Johnson VA.
    AIDS Clin Rev; 1995 Apr 01; ():305-46. PubMed ID: 7488558
    [No Abstract] [Full Text] [Related]

  • 5. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC, Nielsen C, Gerstoft J, Nielsen CM, Vestergaard BF.
    Ugeskr Laeger; 1994 Jan 10; 156(2):185-6. PubMed ID: 7905217
    [Abstract] [Full Text] [Related]

  • 6. [Clinical effectiveness of zidovudine].
    Mulder JW.
    Ned Tijdschr Geneeskd; 1995 Feb 04; 139(5):211-3. PubMed ID: 7854480
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M, Steigbigel R, Staszewski S, Mellors J, Scerpella E, Hirschel B, Lange J, Squires K, Rawlins S, Meibohm A, Leavitt R.
    J Infect Dis; 1999 Sep 04; 180(3):659-65. PubMed ID: 10438352
    [Abstract] [Full Text] [Related]

  • 8. [Antiviral drugs--1988].
    Hirschel B.
    Schweiz Med Wochenschr; 1988 Dec 10; 118(49):1830-7. PubMed ID: 2851167
    [Abstract] [Full Text] [Related]

  • 9. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE, Leuther MD, Allain JP, Nusinoff-Lehrman S, Boone GS, Feigal D, Volberding P.
    Arch Intern Med; 1988 Oct 10; 148(10):2151-3. PubMed ID: 3263098
    [Abstract] [Full Text] [Related]

  • 10. Combination drug therapy for AIDS.
    Science; 1989 May 05; 244(4904):511. PubMed ID: 2497521
    [No Abstract] [Full Text] [Related]

  • 11. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
    Foudraine NA, Jurriaans S, Weverling GJ, Burger DM, Hoetelmans RM, Roos MT, Maas J, Miedema F, Reiss P, Portegies P, de Wolf F, Lange JM.
    Antivir Ther; 2001 Mar 05; 6(1):55-62. PubMed ID: 11417762
    [Abstract] [Full Text] [Related]

  • 12. Prediction of HIV-1 RNA suppression and its durability during treatment with zidovudine/lamivudine.
    Opravil M, Hill AM, DeMasi R, Dawson D.
    Antivir Ther; 1998 Mar 05; 3(3):169-76. PubMed ID: 10682134
    [Abstract] [Full Text] [Related]

  • 13. Phase I/II study of pentoxifylline with zidovudine on HIV-1 growth in AIDS patients.
    Luke DR, McCreedy BJ, Sarnoski TP, Bookout JB, Johnston AM, Lell JE, Wiggan EB, Bell N, Limjuco RA, Guthrie KI.
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul 05; 31(7):343-50. PubMed ID: 8370633
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.
    Parkin NT, Lie YS, Hellmann N, Markowitz M, Bonhoeffer S, Ho DD, Petropoulos CJ.
    J Infect Dis; 1999 Sep 05; 180(3):865-70. PubMed ID: 10438382
    [Abstract] [Full Text] [Related]

  • 15. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A.
    Ann Neurol; 1993 Aug 05; 34(2):206-11. PubMed ID: 8338345
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [HIV infection. Zidovudine and 2',3'-dideoxycytidine in AIDS].
    Walz B.
    Med Monatsschr Pharm; 1988 Dec 05; 11(12):415. PubMed ID: 2850454
    [No Abstract] [Full Text] [Related]

  • 19. Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine.
    Dykes C, Najjar J, Bosch RJ, Wantman M, Furtado M, Hart S, Hammer SM, Demeter LM.
    J Infect Dis; 2004 Mar 15; 189(6):1091-6. PubMed ID: 14999613
    [Abstract] [Full Text] [Related]

  • 20. Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation.
    Barzilai A, Sperling RS, Hyatt AC, Wedgwood JF, Reidenberg BE, Hodes DS.
    Pediatr Infect Dis J; 1990 Dec 15; 9(12):931-3. PubMed ID: 2277754
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.